Tenax Therapeutics (TENX) Earnings Date & Reports

Tenax Therapeutics Inc is a phase three, development-stage pharmaceutical company focused on identifying and developing therapeutics that address cardiovascular and pulmonary diseases with high unmet medical need, with an initial therapeutic focus on pulmonary hypertension... Show more

Industry: #Medical Specialties

Get AI intraday signals

A.I. Advisor

published Earnings

TENX is expected to report earnings to fall 31.43% to -23 cents per share on August 18

Tenax Therapeutics TENX Stock Earnings Reports

Q2'26

Est.

$-0.24

Q1'26

Missed

by $0.12

Q4'25

Missed

by $0.15

Q3'25

Missed

by $0.17

Q2'25

Missed

by $0.06

The last earnings report on May 12 showed earnings per share of -34 cents, missing the estimate of -23 cents. With 560.37K shares outstanding, the current market capitalization sits at 284.61M.

View a ticker or compare two or three

Compare

TENX

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for TENX